Literature DB >> 32021608

Previously Unreported COL7A1 Mutation in a Somali Patient with Dystrophic Epidermolysis Bullosa.

Valeria Venti1, Bruna Scalia1, Alessandra Sauna1, Maria Rita Nasca2, Pierluigi Smilari1, Andrea D Praticò1, Agata Fiumara1, Xena G Pappalardo3, Piero Pavone1.   

Abstract

Epidermolysis bullosa (EB) encompasses a group of inheritable skin disorders characterized by various degrees of epithelial fragility that lead to cutaneous and mucosal blistering following negligible mechanical traumas. These disorders are clinically and genetically heterogeneous, ranging from mild skin involvement to severe disabling conditions with associated manifestations affecting the gastrointestinal and vesico-urinary tracts. EB may be classified into 4 main categories: simplex, junctional, dystrophic, and Kindler syndrome. Clinically, EB may present as syndromic or nonsyndromic forms. EB subtypes have mainly reported a number of mutations in the candidate COL7A1 gene encoding type VII collagen, a major stabilizing molecule of the dermoepidermal junction. Herein, we report a Somali girl with dystrophic EB who showed a previously unreported missense variant c.6797G>T in exon 86 in COL7A1.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  COL7A1 variant; Cutaneous disorders; Dystrophic epidermolysis bullosa; Epidermolysis bullosa; Pathogenetic variants

Year:  2019        PMID: 32021608      PMCID: PMC6995948          DOI: 10.1159/000504210

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  19 in total

Review 1.  Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.

Authors:  Jo-David Fine; Leena Bruckner-Tuderman; Robin A J Eady; Eugene A Bauer; Johann W Bauer; Cristina Has; Adrian Heagerty; Helmut Hintner; Alain Hovnanian; Marcel F Jonkman; Irene Leigh; M Peter Marinkovich; Anna E Martinez; John A McGrath; Jemima E Mellerio; Celia Moss; Dedee F Murrell; Hiroshi Shimizu; Jouni Uitto; David Woodley; Giovanna Zambruno
Journal:  J Am Acad Dermatol       Date:  2014-03-29       Impact factor: 11.527

2.  First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru.

Authors:  A H Saeidian; L Youssefian; G M Rosales-Solis; H Vahidnezhad; V S Atanasova; J Uitto; A P South; J C Salas-Alanis
Journal:  Clin Exp Dermatol       Date:  2018-02-09       Impact factor: 3.470

3.  Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages.

Authors:  Hassan Vahidnezhad; Leila Youssefian; Sirous Zeinali; Amir Hossein Saeidian; Soheila Sotoudeh; Nikoo Mozafari; Maryam Abiri; Abdol-Mohammad Kajbafzadeh; Mohammadreza Barzegar; Adam Ertel; Paolo Fortina; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2016-10-27       Impact factor: 8.551

Review 4.  Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review.

Authors:  Alvin W Li; Brea Prindaville; Scot T Bateman; Timothy E Gibson; Karen Wiss
Journal:  Pediatr Dermatol       Date:  2017-09-25       Impact factor: 1.588

5.  Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency.

Authors:  Hassan Vahidnezhad; Leila Youssefian; Amir Hossein Saeidian; Andrew Touati; Sara Pajouhanfar; Taghi Baghdadi; Azam Ahmadi Shadmehri; Cecilia Giunta; Marius Kraenzlin; Delfien Syx; Fransiska Malfait; Cristina Has; Su M Lwin; Razieh Karamzadeh; Lu Liu; Alyson Guy; Mohammad Hamid; Ariana Kariminejad; Sirous Zeinali; John A McGrath; Jouni Uitto
Journal:  Matrix Biol       Date:  2018-11-18       Impact factor: 11.583

Review 6.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

7.  The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.

Authors:  Chihiro Nakayama; Yasuyuki Fujita; Wakana Matsumura; Inkin Ujiie; Shota Takashima; Satoru Shinkuma; Toshifumi Nomura; Riichiro Abe; Hiroshi Shimizu
Journal:  J Dermatol Sci       Date:  2018-06-18       Impact factor: 4.563

Review 8.  Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.

Authors:  Ningning Dang; Dédée F Murrell
Journal:  Exp Dermatol       Date:  2008-07       Impact factor: 3.960

9.  Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.

Authors:  A H Saeidian; L Youssefian; M G Moreno Trevino; G Fortuna; H Vahidnezhad; V S Atanasova; J Uitto; J C Salas-Alanis; A P South
Journal:  Clin Exp Dermatol       Date:  2018-02-23       Impact factor: 3.470

10.  Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Jeroen Bremer; Olivier Bornert; Alexander Nyström; Antoni Gostynski; Marcel F Jonkman; Annemieke Aartsma-Rus; Peter C van den Akker; Anna Mg Pasmooij
Journal:  Mol Ther Nucleic Acids       Date:  2016-10-18       Impact factor: 10.183

View more
  1 in total

1.  Novel biallelic variants in COL7A1 cause recessive dystrophic epidermolysis bullosa.

Authors:  Neng Yang; Yongyi Ma; Hong Yao; Qing Chang; Victor Zhang; Zhiqing Liang; Xiongwei Cai
Journal:  Mol Genet Genomic Med       Date:  2020-06-14       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.